Month: September 2021

CAMBRIDGE, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) today announced its participation in the following upcoming investor conferences:Morgan Stanley 19th Annual Global Healthcare Conference taking place Thursday, September 9th through Wednesday, September 15thCullinan’s CEO, Owen Hughes, will participate in a virtual fireside chat on Monday, September 13th, at 12:30pm ET, and will provide a corporate update at 4:15pm ETH.C. Wainwright 23rd Annual Global Investment Conference on Monday, September 13th through Wednesday, September 15thCullinan’s Chief Development Officer of Biologics, Jennifer Michaelson, will participate in a panel discussion titled “Engineered Cytokines: The Next Big Wave in Immuno-oncology”, which will be broadcast to conference participants on Tuesday,...

NORTON, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) — CPS Technologies Corp. (Nasdaq:CPSH), announced today that several recent contract awards have resulted in over $11 million in orders this year for a variety of Hermetic Packages offered by CPS. Michael McCormack, President and Chief Executive Officer of CPS, said, “All three of our product lines continue to perform well. In particular, the performance of the Hermetic Package product line continues to achieve record results in terms of revenue, and bookings adding significantly to CPS’s bottom line. We have several large customers that have selected CPS solutions to meet their rigorous requirements. We are pleased to be selected as their partner of choice in these critical applications.” “The continued growth of Hermetic Packages for use in Aerospace, Defense and Power Electronics,...

Expanded access program may allow access for eligible patients in the United States who have no authorized treatment options BOSTON, Sept. 08, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming the care of people living with rare genetic diseases of obesity, today announced an Expanded Access Program (EAP) for setmelanotide for the treatment of eligible patients in the United States with severe obesity and hyperphagia due to Bardet-Biedl Syndrome (BBS). Rhythm expects to submit to the U.S. Food and Drug Administration (FDA) a supplemental new drug application (sNDA) for setmelanotide for the treatment of adult and pediatric patients 6 years of age and older with hunger and obesity due to BBS by the end of September. “BBS is a serious disease...

DALLAS, Sept. 08, 2021 (GLOBE NEWSWIRE) — Capital Southwest Corporation (“Capital Southwest”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, announced today that it recently supported Eden Capital′s (“Eden”) acquisition of Wall Street Prep, Inc. (“WSP”) with a revolving credit facility, first lien term loan, and a minority equity co-investment. Capital Southwest led the financing and will act as the sole administrative agent. Main Street Capital Corporation also participated in the investment. “We are excited to partner with Eden Capital on this transaction as they continue to pursue investments in the education and corporate training sector,” said Ryan Kelly, Managing Director of Capital...

DUBLIN, Ireland and TREVOSE, Pa., Sept. 08, 2021 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc (NASDAQ: SBBP) (the “Company” or “Strongbridge”) today announced that its shareholders have voted to approve the previously announced proposed acquisition of Strongbridge by Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) (“Xeris”). As described below, at least 99 percent of the votes cast at both a special court-ordered meeting of shareholders (the “Court Meeting”) and at an extraordinary general meeting of shareholders (the “EGM”) were in favor of the transaction, representing (in each case) approximately 67 percent of the shares outstanding and eligible to be voted at each of the Strongbridge shareholder meetings held on September 8, 2021 in Pennsylvania, United States of America. Upon close of the transaction, the business of Xeris and...